Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia

NCT04095936 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Aplastic Anemia

Interventions

DRUG: Romiplostim

Sponsor

Kyowa Kirin Co., Ltd.